| 000 | 01663 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516020138.0 | ||
| 264 | 0 | _c20110412 | |
| 008 | 201104s 0 0 eng d | ||
| 022 | _a1466-1861 | ||
| 024 | 7 |
_a10.1155/2010/685903 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAydemir, Selim | |
| 245 | 0 | 0 |
_aHelicobacter pylori eradication lowers serum asymmetric dimethylarginine levels. _h[electronic resource] |
| 260 |
_bMediators of inflammation _c2010 |
||
| 300 |
_a685903 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_a2-Pyridinylmethylsulfinylbenzimidazoles _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmoxicillin _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aArginine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAtherosclerosis _xetiology |
| 650 | 0 | 4 |
_aCardiovascular Abnormalities _xetiology |
| 650 | 0 | 4 |
_aClarithromycin _xadministration & dosage |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHelicobacter Infections _xblood |
| 650 | 0 | 4 |
_aHelicobacter pylori _xpathogenicity |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLansoprazole |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xantagonists & inhibitors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aEren, Haci | |
| 700 | 1 | _aTekin, Ishak Ozel | |
| 700 | 1 | _aHarmandar, Ferda Akbay | |
| 700 | 1 | _aDemircan, Nejat | |
| 700 | 1 | _aCabuk, Mehmet | |
| 773 | 0 |
_tMediators of inflammation _gvol. 2010 _gp. 685903 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1155/2010/685903 _zAvailable from publisher's website |
| 999 |
_c20483745 _d20483745 |
||